Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Los Angeles Capital Management LLC

Los Angeles Capital Management LLC decreased its position in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 74.3% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 3,667 shares of the medical research company’s stock after selling 10,614 shares during the quarter. Los Angeles Capital […]

Related Keywords

Canada ,United States ,Blackrock ,California ,Los Angeles ,America ,Adara Wright ,Michael Crowley ,Blackrock Inc ,Brown Advisory Inc ,Securities Exchange Commission ,Vanguard Group Inc ,America Corp ,Bio Rad Laboratories Inc ,Exchange Commission ,Los Angeles Capital Management ,Bio Rad Laboratories ,Free Report ,Angeles Capital Management ,Street Corp ,Rad Laboratories ,Life Science ,Clinical Diagnostics ,Visit Holdingschannel ,Bio Rad Laboratories Daily ,Nyse Bio ,Bio ,Medical ,09057220 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,